Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
And when it comes to the 2025 NFL Draft, analysts expect defense to be particularly popular for the Jaguars early. This is the second jaguars.com 2025 mock draft tracker – with two defensive players ...
Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.
JOHNSON COUNTY, Tenn. (WCYB) — Update: The suspect arrested in Elizabethton following a shooting in Johnson County has been ...
One of President Donald Trump's executive orders offers a new federal government definition of the sexes that could have a ...